Microbiome Research for Precision Medicine

CBmed offers a wide array of services and expertise to investigate the relationship between the gut microbiome, gut permeability and response to different compounds to investigate multimodal cancer therapies. CBmed hosts an innovative microbiome modulation platform where the effects of compounds can be recapitulated in an in vitro setting using human biospecimens. This model of the human gut microbiome can be easily adapted to investigate disease and allows for the understanding of the pathophysiology of disease-therapeutic-microbiome interactions. It also allows for the design of rational strategies to improve efficacy and ameliorate side effects of drugs and compounds under investigation. Furthermore, new or repurposed small molecules that have a positive impact on gut microbiome composition or function can be explored.

We are open to offer our expertise as a service to your project and/or collaborate on the conception and execution of a joint project.